The Flinn Foundation has opened the application for the next round of the Seed Grants to Promote Translational Research Program, which will fund up to 10 research teams focused on advancing new products or services to improve patient care.
The awardees will each receive a $100,000 grant over 18 months. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.
The deadline to apply is Dec. 3.
The research teams must be affiliated with Arizona’s academic research institutions and/or health-care systems. The proposed projects must address compelling clinical needs in the areas of precision medicine, diagnostics, devices, therapeutics, or health-care-delivery processes and have significant potential to turn bench results into viable products or systems impacting patients in Arizona and beyond.
There program brochure provides additional information about the program benefits, eligibility, and expectations.
“It is profoundly challenging to shepherd a research project from the first lab experiment to real-world applications and positive patient outcomes—even for the most experienced teams,” said Mary O’Reilly, Ph.D., Flinn Foundation’s vice president, bioscience research programs. “Our translational seed-grants program accelerates the process, with funding, yes, but with guidance and invaluable connections, too.”
The Seed Grants to Promote Translational Research Program has awarded 41 grants totaling $5.29 million since 2013.
The awardees for the 2022 program will be announced in March.
Learn more about the program at www.flinn.org/seedgrants, or contact Mary O’Reilly, Ph.D., vice president, bioscience research programs, at email@example.com or Juliet Gomez, bioscience program manager, at firstname.lastname@example.org.